UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

Clinical cancer research, 2008-08, Vol.14 (16), p.5000-5005

2008

Volltextzugriff (PDF)

Autophagy inhibition enhances vorinostat‐induced apoptosis via ubiquitinated protein accumulation

Journal of cellular and molecular medicine, 2010-10, Vol.14 (10), p.2448-2459

2010

Volltextzugriff (PDF)

Heat shock proteins: a potential anticancer target

Current drug targets, 2011-12, Vol.12 (14), p.2001-2008

2011

Volltextzugriff (PDF)

Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies

Journal of clinical oncology, 2008-01, Vol.26 (3), p.361-367

2008

Volltextzugriff (PDF)

Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats

Nanomedicine, 2018-08, Vol.14 (6), p.1905-1917

2018

Volltextzugriff (PDF)

Bromodomain inhibitors a decade later: a promise unfulfilled?

British journal of cancer, 2020-12, Vol.123 (12), p.1713-1714

2020

Volltextzugriff (PDF)

Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas

Oncotarget, 2017-10, Vol.8 (49), p.86769-86783

2017

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors

Clinical cancer research, 2009-01, Vol.15 (2), p.723-730

2009

Volltextzugriff (PDF)

A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies

Clinical cancer research, 2009-06, Vol.15 (12), p.4207-4212

2009

Volltextzugriff (PDF)

Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels

Clinical cancer research, 2010-01, Vol.16 (1), p.141-153

2010

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of CT-322 (BMS-844203), a Targeted Adnectin Inhibitor of VEGFR-2 Based on a Domain of Human Fibronectin

Clinical cancer research, 2011-01, Vol.17 (2), p.363-371

2011

Volltextzugriff (PDF)

Cross-Linked and Functionalized Acrylic Polymers: Efficient and Reusable Sorbents for Zn(II) Ions in Solution

Journal of polymers and the environment, 2021-07, Vol.29 (7), p.2261-2281

2021

Volltextzugriff (PDF)

Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer

British journal of cancer, 2011-09, Vol.105 (7), p.938-944

2011

Volltextzugriff (PDF)

An explanatory framework of teachers' perceptions of a positive mealtime environment in a preschool setting

Appetite, 2015-07, Vol.90, p.37-44

2015

Volltextzugriff (PDF)

Combined high‐intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base

Cancer, 2017-12, Vol.123 (23), p.4583-4593

2017

Volltextzugriff (PDF)

Stage I HPV‐positive oropharyngeal cancer: Should all patients receive similar treatments?

Cancer, 2020-01, Vol.126 (1), p.58-66

2020

Volltextzugriff (PDF)

Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors

Clinical cancer research, 2016-07, Vol.22 (13), p.3157-3163

2016

Volltextzugriff (PDF)

A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma

Clinical cancer research, 2015-02, Vol.21 (3), p.585-593

2015

Volltextzugriff (PDF)

Definitions of remission in psoriasis: a systematic literature review from the National Psoriasis Foundation

Journal of the European Academy of Dermatology and Venereology, 2022-12, Vol.36 (12), p.2291-2300

2022

Volltextzugriff (PDF)

Combined autophagy and HDAC inhibition: A phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors

Autophagy, 2014-08, Vol.10 (8), p.1403-1414

2014

Volltextzugriff (PDF)

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2117-2124

2017

Volltextzugriff (PDF)

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2014-09, Vol.85 (3), p.429-434

2014

Volltextzugriff (PDF)

Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?

Clinical cancer research, 2012-12, Vol.18 (24), p.6574-6579

2012

Volltextzugriff (PDF)

Development of a peptide-based bifunctional chelator conjugated to a cytotoxic drug for the treatment of melanotic melanoma

MedChemComm, 2018-05, Vol.9 (5), p.812-826

2018

Volltextzugriff (PDF)

Reminiscent Net: Conditional GAN-based Old Image De-Creasing

International journal of image and graphics, 2021-10, Vol.21 (4)

2021

Volltextzugriff (PDF)

1 – 25 von 1.024

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(880)
Mit Volltextzugriff
(888)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(551)
Life Sciences & Biomedicine
(391)
Humans
(257)
Female
(172)
Male
(152)
Biological And Medical Sciences
(127)
Adult
(122)
Technology
(113)
Physical Sciences
(95)
Middle Aged
(94)
Animals
(87)
Oncology
(86)
Medical Sciences
(80)
Aged
(77)
Engineering
(65)
Fundamental And Applied Biological Sciences. Psychology
(57)
Materials Science
(52)
Sport Sciences
(50)
Neoplasms - Drug Therapy
(43)
Chemistry
(42)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

Autophagy inhibition enhances vorinostat‐induced apoptosis via ubiquitinated protein accumulation

Heat shock proteins: a potential anticancer target

Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies

Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats

Bromodomain inhibitors a decade later: a promise unfulfilled?

Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas

Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors

A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies

Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels

Phase I and Pharmacokinetic Study of CT-322 (BMS-844203), a Targeted Adnectin Inhibitor of VEGFR-2 Based on a Domain of Human Fibronectin

Cross-Linked and Functionalized Acrylic Polymers: Efficient and Reusable Sorbents for Zn(II) Ions in Solution

Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer

An explanatory framework of teachers' perceptions of a positive mealtime environment in a preschool setting

Combined high‐intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base

Stage I HPV‐positive oropharyngeal cancer: Should all patients receive similar treatments?

Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors

A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma

Definitions of remission in psoriasis: a systematic literature review from the National Psoriasis Foundation

Combined autophagy and HDAC inhibition: A phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma

Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?

Development of a peptide-based bifunctional chelator conjugated to a cytotoxic drug for the treatment of melanotic melanoma

Reminiscent Net: Conditional GAN-based Old Image De-Creasing

Suchergebnisse filtern